Market Closed -
NSE India S.E.
05:10:47 29/04/2024 pm IST
|
5-day change
|
1st Jan Change
|
306.2
INR
|
-0.08%
|
|
+12.91%
|
+22.63%
|
Fiscal Period: March |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
3,60,832
|
3,20,015
|
4,84,623
|
3,99,173
|
2,46,192
|
3,65,539
|
-
|
-
|
Enterprise Value (EV)
1 |
3,56,129
|
3,29,826
|
4,81,237
|
4,20,987
|
3,99,898
|
5,04,760
|
5,08,486
|
5,01,837
|
P/E ratio
|
40.2
x
|
42.9
x
|
66.1
x
|
61.9
x
|
53.3
x
|
38.5
x
|
42.9
x
|
25.4
x
|
Yield
|
0.16%
|
0.18%
|
-
|
0.15%
|
0.73%
|
0.43%
|
0.47%
|
0.64%
|
Capitalization / Revenue
|
6.54
x
|
5.03
x
|
6.82
x
|
4.88
x
|
2.2
x
|
2.52
x
|
2.2
x
|
1.87
x
|
EV / Revenue
|
6.46
x
|
5.18
x
|
6.77
x
|
5.14
x
|
3.58
x
|
3.48
x
|
3.07
x
|
2.57
x
|
EV / EBITDA
|
25.6
x
|
20.6
x
|
29.2
x
|
21.4
x
|
17.1
x
|
16.7
x
|
13.4
x
|
10.7
x
|
EV / FCF
|
-528
x
|
-103
x
|
-135
x
|
-80.8
x
|
156
x
|
32
x
|
36.5
x
|
28.7
x
|
FCF Yield
|
-0.19%
|
-0.97%
|
-0.74%
|
-1.24%
|
0.64%
|
3.12%
|
2.74%
|
3.48%
|
Price to Book
|
6.01
x
|
4.84
x
|
6.37
x
|
4.76
x
|
1.39
x
|
1.91
x
|
1.82
x
|
1.68
x
|
Nbr of stocks (in thousands)
|
11,81,990
|
11,82,830
|
11,85,188
|
11,89,431
|
11,93,080
|
11,93,988
|
-
|
-
|
Reference price
2 |
305.3
|
270.6
|
408.9
|
335.6
|
206.4
|
306.4
|
306.4
|
306.4
|
Announcement Date
|
25/04/19
|
14/05/20
|
28/04/21
|
28/04/22
|
23/05/23
|
-
|
-
|
-
|
Fiscal Period: March |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
55,144
|
63,672
|
71,058
|
81,840
|
1,11,742
|
1,45,005
|
1,65,808
|
1,95,031
|
EBITDA
1 |
13,937
|
16,031
|
16,506
|
19,702
|
23,447
|
30,198
|
37,940
|
46,733
|
EBIT
1 |
9,459
|
10,509
|
9,355
|
11,560
|
12,316
|
14,711
|
22,262
|
30,755
|
Operating Margin
|
17.15%
|
16.5%
|
13.17%
|
14.13%
|
11.02%
|
10.15%
|
13.43%
|
15.77%
|
Earnings before Tax (EBT)
1 |
12,149
|
11,860
|
10,774
|
9,831
|
8,971
|
13,493
|
15,353
|
23,596
|
Net income
1 |
9,053
|
7,482
|
7,405
|
6,484
|
4,627
|
9,492
|
9,296
|
14,089
|
Net margin
|
16.42%
|
11.75%
|
10.42%
|
7.92%
|
4.14%
|
6.55%
|
5.61%
|
7.22%
|
EPS
2 |
7.600
|
6.300
|
6.190
|
5.420
|
3.870
|
7.961
|
7.143
|
12.07
|
Free Cash Flow
1 |
-675
|
-3,211
|
-3,572
|
-5,212
|
2,565
|
15,765
|
13,943
|
17,481
|
FCF margin
|
-1.22%
|
-5.04%
|
-5.03%
|
-6.37%
|
2.3%
|
10.87%
|
8.41%
|
8.96%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
10.94%
|
52.21%
|
36.75%
|
37.41%
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
55.44%
|
166.09%
|
149.99%
|
124.07%
|
Dividend per Share
2 |
0.5000
|
0.5000
|
-
|
0.5000
|
1.500
|
1.322
|
1.428
|
1.946
|
Announcement Date
|
25/04/19
|
14/05/20
|
28/04/21
|
28/04/22
|
23/05/23
|
-
|
-
|
-
|
Fiscal Period: March |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
---|
Net sales
1 |
18,510
|
18,387
|
17,606
|
18,404
|
21,742
|
24,088
|
21,395
|
23,197
|
29,411
|
37,739
|
34,226
|
36,196
|
36,732
|
38,945
|
37,706
|
EBITDA
1 |
3,995
|
4,358
|
3,893
|
4,458
|
4,882
|
5,919
|
3,994
|
4,707
|
6,443
|
9,572
|
7,144
|
8,475
|
8,373
|
8,219
|
-
|
EBIT
1 |
2,132
|
2,515
|
1,945
|
2,443
|
2,825
|
3,797
|
1,819
|
2,399
|
3,432
|
5,935
|
3,564
|
4,572
|
4,553
|
4,102
|
3,351
|
Operating Margin
|
11.52%
|
13.68%
|
11.05%
|
13.27%
|
12.99%
|
15.76%
|
8.5%
|
10.34%
|
11.67%
|
15.73%
|
10.41%
|
12.63%
|
12.4%
|
10.53%
|
8.89%
|
Earnings before Tax (EBT)
1 |
2,363
|
3,661
|
1,657
|
2,060
|
2,689
|
3,425
|
1,969
|
2,291
|
-255
|
4,966
|
1,837
|
2,676
|
2,930
|
2,319
|
-
|
Net income
1 |
1,686
|
2,532
|
844
|
1,383
|
1,871
|
2,386
|
1,444
|
470
|
-418
|
3,132
|
1,014
|
1,652
|
1,808
|
2,164
|
-
|
Net margin
|
9.11%
|
13.77%
|
4.79%
|
7.51%
|
8.61%
|
9.91%
|
6.75%
|
2.03%
|
-1.42%
|
8.3%
|
2.96%
|
4.56%
|
4.92%
|
5.56%
|
-
|
EPS
2 |
1.400
|
2.120
|
0.7100
|
1.160
|
1.560
|
1.990
|
1.210
|
0.3900
|
-0.3500
|
2.620
|
0.8500
|
1.460
|
1.620
|
1.150
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
21/01/21
|
28/04/21
|
22/07/21
|
21/10/21
|
20/01/22
|
28/04/22
|
27/07/22
|
14/11/22
|
14/02/23
|
23/05/23
|
10/08/23
|
-
|
-
|
-
|
-
|
Fiscal Period: March |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
9,811
|
-
|
21,814
|
1,53,706
|
1,39,220
|
1,42,947
|
1,36,298
|
Net Cash position
1 |
4,703
|
-
|
3,386
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
0.612
x
|
-
|
1.107
x
|
6.555
x
|
4.61
x
|
3.768
x
|
2.917
x
|
Free Cash Flow
1 |
-675
|
-3,211
|
-3,572
|
-5,212
|
2,565
|
15,765
|
13,943
|
17,481
|
ROE (net income / shareholders' equity)
|
16.1%
|
11.7%
|
10.3%
|
9.16%
|
3.52%
|
3.45%
|
5.12%
|
7.54%
|
ROA (Net income/ Total Assets)
|
8.16%
|
5.62%
|
4.49%
|
3.78%
|
1.28%
|
1.5%
|
1.95%
|
3.1%
|
Assets
1 |
1,10,911
|
1,33,181
|
1,64,922
|
1,71,516
|
3,62,192
|
6,32,803
|
4,76,723
|
4,54,481
|
Book Value Per Share
2 |
50.80
|
55.90
|
64.20
|
70.50
|
149.0
|
161.0
|
168.0
|
182.0
|
Cash Flow per Share
2 |
9.690
|
10.80
|
9.690
|
9.840
|
15.50
|
21.40
|
19.20
|
44.80
|
Capex
1 |
12,221
|
16,042
|
15,169
|
16,978
|
15,960
|
21,612
|
18,628
|
17,112
|
Capex / Sales
|
22.16%
|
25.19%
|
21.35%
|
20.75%
|
14.28%
|
14.9%
|
11.23%
|
8.77%
|
Announcement Date
|
25/04/19
|
14/05/20
|
28/04/21
|
28/04/22
|
23/05/23
|
-
|
-
|
-
|
Last Close Price
306.4
INR Average target price
279.1
INR Spread / Average Target -8.91% Consensus |
1st Jan change
|
Capi.
|
---|
| +22.63% | 4.39B | | -2.63% | 103B | | +1.67% | 95.28B | | +1.75% | 22.15B | | -15.31% | 21.02B | | -8.58% | 18.15B | | -41.01% | 16.73B | | -13.27% | 16.05B | | +4.02% | 13.68B | | +34.74% | 12.17B |
Bio Therapeutic Drugs
|